F. Casas

Publications

70

Citations

510

h-index

11

Publishing journals

25

Years of publications

20+

Active since

2007

References

1.4K

Institutions

7

1. 158P Neoadjuvant treatment in stage III NSCLC: Comparison with NADIM 2 trial as a gold standard
   ESMO Open, Volume 9, No. 102913, Pages 102913-102913, Year 2024
2. PO-2332 Should we limit the maximum dose in inverse-planning-based lung SBRT plans?
   Radiotherapy and Oncology, Volume 182, Pages S2099-S2100, Year 2023
3. Hematological Toxicity in Lung Cancer
   Medical Radiology, Pages 907-923, Year 2022
4. MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer
   Journal of Thoracic Oncology, Volume 16, Issue 3, Pages S141-S141, Year 2021
5. Ten-Year Results of a Phase III Randomised Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localised Prostate Cancer
   SSRN Electronic Journal, Year 2021
6. OC-0338 Prognostic value of testosterone following androgen deprivation and high-dose radiotherapy in prostate cancer
   Radiotherapy and Oncology, Volume 161, Pages S251-S252, Year 2021
7. P18.03 Randomized Trial With BIALOE to Prevent Esophagitis in Lung Cancer Patients Treated With Concurrent Radical Chemoradiotherapy
   Journal of Thoracic Oncology, Volume 16, Issue 3, Pages S354-S354, Year 2021
8. Diagnostic utility and therapeutic impact of PET/CT [18F]F-fluoromethylcholine in the biochemical recurrence of prostate cancer
   Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), Volume 39, Issue 5, Pages 284-291, Year 2020
9. Prognostic Value of Testosterone Levels Following Androgen Deprivation And High Dose Radiotherapy In Localized Prostate Cancer: Results From Dart 01/05 Phase III Trial
   International Journal of Radiation Oncology*Biology*Physics, Volume 108, Issue 3, Pages e858-e858, Year 2020
10. Spanish validation of Charlson index applied to prostate cancer
    Clinical and Translational Oncology, Volume 22, Issue 7, Pages 1187-1192, Year 2019
11. Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment)
    Clinical and Translational Oncology, Volume 22, Issue 6, Pages 802-803, Year 2019
12. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
    Clinical and Translational Oncology, Volume 21, Issue 3, Pages 355-362, Year 2018
13. Combined modality therapy in Stage IIIA non–small cell lung cancer: clarity or confusion despite the highest level of evidence?
    Journal of Radiation Research, Volume 58, Issue 3, Pages 267-272, Year 2017
14. Radiation Therapy
    International Encyclopedia of Public Health, Pages 260-268, Year 2017
15. OBSOLETE: Radiation Therapy
    Reference Module in Biomedical Sciences, Year 2017
16. Surgery for Stage IIIA Non–Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It
    Clinical Lung Cancer, Volume 17, Issue 2, Pages 107-112, Year 2016
17. Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study
    Clinical and Translational Oncology, Volume 19, Issue 3, Pages 373-378, Year 2016
18. No Role For Trimodality Therapy and Consolidation Chemotherapy Compared With Concurrent Radiochemotherapy Alone in Stage III Non–Small-Cell Lung Cancer
    Journal of Clinical Oncology, Volume 34, Issue 2, Pages 196-197, Year 2016
19. Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial
    International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 2, Pages S139-S140, Year 2016
20. Could radiotherapy produce a systemic synergistic effect when combined with abiraterone in patients with prostate cancer resistant to castration?
    European Journal of Cancer, Volume 61, Pages S159-S159, Year 2016

No publications in the index yet.